Inventor

Tze-Chein Wun

Inventor

St. Louis, MO, US

Overview

1990–2008

Patent span

Human necessities

Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes42%

C07KPeptides30%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%

C12NMicroorganisms or enzymes8%

C12YEnzymes8%

PatentTitleYear

7,378,393'Recombinant anticoagulant proteins'2008 7,060,805'Methods for isolating tissue factor inhibitor'2006 6,806,360'Nucleic acids encoding human tissue factor inhibitor'2004 6,534,276'Methods for detecting human tissue factor inhibitor'2003 6,291,427'Anticoagulant combination of LACI and sulfated polysaccharides'2001 6,171,587'Antibodies to tissue factor inhibitor'2001 RE036476'Method of inhibiting microvascular thrombosis'1999 5,914,316'Method of inhibiting intimal hyperplasia'1999 5,849,875'Human tissue factor inhibitor'1998 5,849,703'Pre-formed anticoagulant heparin/TFPI complexes'1998 5,824,660'Method of inhibiting glomerulonephritis'1998 5,773,251'DNA clone of human tissue factor inhibitor'1998 5,648,331'Method of inhibiting tissue ischemia and reperfusion injury'1997 5,466,783'Human tissue factor inhibitor'1995 5,276,015'Method of inhibiting microvascular thrombosis'1994 5,244,676'Modified tissue plasminogen activator with modified glycosylation site'1993 5,212,091'Method of producing tissue factor pathway inhibitor'1993 5,112,955'Method of stabilizing plasminogen activator inhibitor by treatment with vitronectin'1992 5,100,666'Modified tissue plasminogen activator K2K2SP'1992 5,073,626'Affinity purification of plasminogen activator inhibitor I using a modified urokinase'1991 5,037,752'Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277'1991 5,028,534'DNA clones of human placental plasminogen activator inhibitor'1991 4,966,852'DNA clone of human tissue factor inhibitor'1990 4,963,357'Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor'1990

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1990–1995Patents assigned to MONSANTO CO (10)· patent assignee history

1990–2006Patents assigned to UNIV WASHINGTON (7)· patent assignee history

1990–2001Based in St. Louis, MO, US· patent location history

1997–2004Patents assigned to SEARLE & CO (9)· patent assignee history

2001–2008Based in Ballwin, MO, US· patent location history

2008Patents assigned to WUN TZE CHEIN (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MONSANTO CO	10	1990–1995
SEARLE & CO	9	1997–2004
UNIV WASHINGTON	7	1990–2006
WUN TZE CHEINself	1	2008

Locations

Location	Patents	Span
St. Louis, MO, US	19	1990–2001
Ballwin, MO, US	5	2001–2008